Zhiqiang Ku

Brown Foundation — United States

Medicine · Health Sciences

32h-index6.1kcitations74works6.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Viral Infections and Immunology Research(24), SARS-CoV-2 and COVID-19 Research(23), Viral gastroenteritis research and epidemiology(16), Animal Disease Management and Epidemiology(13), Cytokine Signaling Pathways and Interactions(11)

Publications74 total

Author Correction: Nasal delivery of an IgM offers broad protection from SARS-CoV-2 variants
Nature·2025Open Access
Blocking Oncostatin M receptor abrogates STAT3 mediated integrin signaling and overcomes chemoresistance in ovarian cancer
npj Precision Oncology·2024· 13 citedOpen Access
Transcriptional signature of durable effector T cells elicited by a replication defective HCMV vaccine
npj Vaccines·2024· 7 citedOpen Access
An ACE2 decamer viral trap as a durable intervention solution for current and future SARS-CoV
Emerging Microbes & Infections·2023· 3 citedOpen Access
An ACE2 decamer viral trap as a durable intervention solution for current and future SARS-CoV
2023Open Access
Overcoming adaptive resistance to anti-VEGF therapy by targeting CD5L
Nature Communications·2023· 34 citedOpen Access
Abstract 3653: Oncostatin m receptor signaling reprograms tumor microenvironment for chemoresistance
Cancer Research·2023
Data from Oncostatin M Receptor–Targeted Antibodies Suppress STAT3 Signaling and Inhibit Ovarian Cancer Growth
2023Open Access
SupplementaryMethods.docx from Oncostatin M Receptor–Targeted Antibodies Suppress STAT3 Signaling and Inhibit Ovarian Cancer Growth
2023Open Access
Combined Supplementary Data from Oncostatin M Receptor–Targeted Antibodies Suppress STAT3 Signaling and Inhibit Ovarian Cancer Growth
2023Open Access
Supplementary Data from Oncostatin M Receptor–Targeted Antibodies Suppress STAT3 Signaling and Inhibit Ovarian Cancer Growth
2023Open Access
Combined Supplementary Data from Oncostatin M Receptor–Targeted Antibodies Suppress STAT3 Signaling and Inhibit Ovarian Cancer Growth
2023Open Access
SupplementaryMethods.docx from Oncostatin M Receptor–Targeted Antibodies Suppress STAT3 Signaling and Inhibit Ovarian Cancer Growth
2023Open Access
Supplementary Data from Oncostatin M Receptor–Targeted Antibodies Suppress STAT3 Signaling and Inhibit Ovarian Cancer Growth
2023Open Access
Data from Oncostatin M Receptor–Targeted Antibodies Suppress STAT3 Signaling and Inhibit Ovarian Cancer Growth
2023Open Access
A potent and broad neutralization of SARS-CoV-2 variants of concern by DARPins
Nature Chemical Biology·2022· 19 citedOpen Access
Engineering SARS-CoV-2 specific cocktail antibodies into a bispecific format improves neutralizing potency and breadth
Nature Communications·2022· 45 citedOpen Access
Blocking LAIR1 signaling in immune cells inhibits tumor development
Frontiers in Immunology·2022· 31 citedOpen Access
LILRB2-mediated TREM2 signaling inhibition suppresses microglia functions
Molecular Neurodegeneration·2022· 44 citedOpen Access
Potent and pan-neutralization of SARS-CoV-2 variants of concern by DARPins
2022· 2 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

Zhiqiang An(29), Xiaohua Ye(23), Qingwei Liu(21), Zhong Huang(21), Ningyan Zhang(17), Vineet D. Menachery(15), Xuping Xie(15), Pei‐Yong Shi(15), Scott C. Weaver(11), Antonio E. Muruato(10), Jessica A. Plante(9), Xianwen Zhang(9), Kenneth S. Plante(9), Bryan A. Johnson(8), Jing Zou(8), Hang Su(8), Hongjie Xia(7), Dionna Scharton(7), Birte Kalveram(7), Craig Schindewolf(7)